To date, cardiologists have alleviated the symptoms of patients with significant lesions in the coronary angiography by stenting or coronary artery bypass grafting. While normal-looking coronary segments in angiography have been regarded as 'disease-free' and mild/moderate stenoses as 'non-treatable', today that we know that from these non-significantly diseased areas may potentially arise acute coronary events if no further action is taken other than standard care for cardiovascular risk factors. Indeed, despite intensive management, many patients continue to experience recurrent coronary events. 1 In response to this, many researchers have recently turned their eyes towards the study of areas with mild to moderate atherosclerotic disease. Some researchers have even tried to focally modify the natural course of the non-significant stenoses by applying local therapies.
Advances in the Invasive Diagnosis and Treatment of Vulnerable Coronary Plaques
Hector M Garcia-Garcia is an interventional cardiologist who in his recent work has attempted to provide a comprehensive definition of high-risk plaques using intravascular ultrasound radiofrequency data analysis. He is currently supervising cardiologists across the whole range of invasive intravascular imaging techniques, such as virtual histology, palpography, optical coherence tomography and raman spectroscopy. Dr Garcia has a Masters of Health Science in Medicine from Erasmus University in Rotterdam. Interventional Cardiology as glistening white, whereas atherosclerotic plaques can be categorised based on their angioscopic colour as yellow or white. Platelet-rich thrombus at the site of plaque rupture is characterised as white granular material, and fibrin/erythrocyte-rich thrombus as an irregular red structure protruding into the lumen. Yellow plaques are associated with acute coronary syndromes (ACS) 7 and thrombosis. 8 The major limitations of angioscopy are:
• it requires a blood-free field during image acquisition, which can be obtained either by complete vessel occlusion or by continuous saline flushing in front of the angioscope;
• only a limited part of the coronary tree can be investigated (i.e. vessels >2mm diameter); and
• assessment of stenotic lesions may prove difficult.
Kubo et al. 9 reported the ability of OCT to assess the culprit lesion (CL) morphology in AMI in comparison with IVUS and CAS. The incidence of plaque rupture observed by OCT was 73%, by CAS 47% (p=0.035) and by IVUS 40% (p=0.009). Furthermore, OCT (23%) was superior to CAS (3%; p=0.022) and IVUS (0%; p=0.005) in the detection of fibrous cap erosion. The intracoronary thrombus was observed in all cases by OCT and CAS, but it was identified in only 33% by IVUS (p<0.001 versus OCT). More recently, Kubo et al. 10 assessed the relationship between plaque colour evaluated by CAS and fibrous cap thickness estimated by OCT in vivo. To this end, 77 coronary artery plaques in patients with ACS were analysed. Plaque colour varied with respect to the fibrous cap thickness: 389±74µm in white plaques, 228±51µm in light yellow plaques, 115±28µm in yellow plaques and 59±14µm in intensive yellow plaques (p<0.0001) (see Figure 1) . In Spearman rank-order correlation analysis, there was a significant negative correlation between yellow colour intensity and fibrous cap thickness (p<0.0001). Furthermore, 80% of intensive yellow plaques were TCFA with a cap thickness of 65µm.
Greyscale Intravascular Ultrasound
This is currently the gold standard for intracoronary imaging in progression/regression plaque trials. In addition, visual assessment of plaque echogenicity provides semi-quantitative tissue characterisation.
Calcification can be identified as bright echo signals with acoustic shadowing, with a sensitivity and specificity of approximately 90%. Lipid deposits, visualised as echolucent zones, can be detected with high sensitivity (78-95%) but low specificity (30%). Moreover, the axial resolution of IVUS is in the range of 100-150µm, whereas the fibrous cap of a TCFA is thinner than 65µm and therefore cannot be visualised by IVUS. Despite these limitations, large eccentric plaques containing an echolucent zone as assessed by IVUS were associated with the development of ACS in a prospective study. 11 Some of the limitations of IVUS can be improved by analysing the echogenicity or backscattered ultrasound signal, which are more sophisticated techniques for tissue characterisation. Recently, an ex vivo feasibility study showed that automated 3D differential echogenicity analysis of IVUS images allowed identification of different tissue types within atherosclerotic plaques. 12 Plaques were scored for echogenicity compared with adventitia as either An in vitro comparison of OCT, integrated backscatter IVUS -using a similar methodology to IVUS: VH -and conventional IVUS found that OCT had the best potential for tissue characterisation of coronary plaques, with higher sensitivity and specificity compared with the other imaging modalities. 13 However, a recent study comparing OCT with histopathology reported a lower sensitivity for plaque components. Misclassification occurred in 41% of lesions, predominantly due to a combination of incomplete penetration depth into the vessel wall and the inability to distinguish calcium deposits from lipid pools. 14 As a result of its high axial resolution, there is no doubt that OCT is the Recently, in 56 patients with angina (126 plaques), the combined use of IVUS-VH and OCT for detecting TCFAs in vivo has been reported. 16 IVUS-derived TCFAs (IDTCFAs) were defined as >10% necrotic core of the cross-sectional area (CSA) in contact with the lumen (NCCL) and plaque burden >40%. OCT-derived TCFAs were defined as a fibrous cap thickness of <65µm overlying a low-intensity area with an unclear border. Plaque meeting both TCFA criteria was defined as definite 
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Western Approach
Intravascular Ultrasound Radiofrequency AnalysisVirtual Histology
IVUS-VH (Volcano Corp., Rancho Cordoba, US) involves spectral analysis to construct tissue maps that classify plaque into four major components: fibrous (green), fibro-fatty (light green), necrotic core (red) and dense calcium (white).
Our group evaluated the incidence of IDTCFA using IVUS-VH.
ACS patients had a significantly higher incidence of IDTCFA than stable patients Patients presenting with ACS had a significantly higher prevalence of IDTCFAs even in non-culprit vessels, supporting the concept of a multifocal process. Of note, the lesion percentage area stenosis and the mean necrotic core areas of the IDTCFAs detected by IVUS-VH were also similar to previously reported histopathological data (55.9 and 59.6% and 19 and 23%, respectively).
We have developed software to quantify the amount of necrotic core in contact with the lumen, enabling the refinement of our analysis.
Our current definition of an IDTCFA is a lesion fulfilling the following two criteria in at least three consecutive CSAs: plaque burden ≥40%, and confluent necrotic core ≥10% in direct contact with the lumen (i.e. 
Intravascular Ultrasound Radiofrequency
Analysis -Palpography
This technique allows the assessment of local mechanical tissue properties. For a defined pressure difference, soft-tissue (e.g. lipidrich) components will deform to a greater extent than hard-tissue components (e.g. fibrous, calcified). Radiofrequency data obtained at different pressure levels are compared to determine the local tissue deformation. 19 The local strain is calculated from the gated radiofrequency traces using cross-correlation analysis and displayed in colour-coded manner, from blue (for a 0% strain) to red to yellow (for a 2% strain). Plaque strain values are assigned a Rotterdam Classification (ROC) score: ROC I = 0-<0.6%, ROC II = 0.6-<0.9%, ROC III = 0.9-<1.2% and ROC IV = >1.2% (see Figure 1) . 20 In a subsequent study, 55 patients with stable angina, unstable angina or AMI were analysed. Among patients with stable angina, the prevalence of deformable plaques per vessel was significantly lower (0.6±0.6) than in unstable angina patients (1.6±0.7; p=0.0019) or AMI patients (2.0±0.7; p<0.0001). 21 In IBIS I, on palpography both the absolute number of high-strain spots (ROC III/IV) in the region of interest A confluent necrotic core (red) at the lumen can be seen in the first three consecutive frames.
Figure 1: Invasive Imaging Approaches
The Eastern approach aims at imaging the same coronary segment using three different imaging modalities.
Although it has been proved to be feasible, it requires two balloon occlusions -for angioscopy and optical coherence tomography (OCT) -and three different pullbacks. An intensive yellow plaque is observed in the angioscopy, which corresponds to a low-reflectivity plaque with a thin fibrous cap in OCT. In contrast, the Western approach uses only one catheter from which three different types of information are derived; no occlusions are required. The same plaque is simultaneously analysed with greyscale intravenous ultrasound (IVUS), palpography (where a high strain -Rotterdam Classification [ROC] III -is visible) and virtual histology (VH; confluent necrotic core -red -is seen at the lumen, which is co-localised with the ROC III).
Images of angioscopy and optical coherence tomography are courtesy of Dr Takashi Kubo.
Two approaches, common ultimate goal 
Interventional Cardiology
Other Imaging Techniques
Thermography
Atherosclerosis is accompanied by inflammation, and vulnerable plaques have been associated with increased macrophage activity, metabolism and inflammation. 23 In a prospective study, an association between temperature heterogeneity and the incidence of adverse events at followup was found in patients with coronary artery disease undergoing a successful percutaneous intervention. 24 In addition, treatment with statins seems to affect the thermographic results: in non-CLs the temperature difference (DeltaT) was lower in the group treated with statins compared with the untreated group (0.06±0.05 versus 0.11±0.10°C; p=0.05). 25 More recently, a correlation between the morphological and functional characteristics of CLs in patients with ACS and chronic stable angina has been reported. 26 There are a few limitations to the routine use of thermography in the catheterisation laboratory:
• most of the catheters used still comprise over-the-wire systems;
• accurate temperature assessment requires direct contact of the thermistors with the vessel wall, with the associated potential risk of endothelial damage; and
• because the temperature within the vessel changes rapidly with fluid application, any intracoronary injection of contrast dye, flush or medication has to be avoided before and during measurements.
Raman and Near-infrared Spectroscopy
A number of spectroscopic intravascular imaging techniques have been developed recently and are still under investigation. 28 29, 30 and can therefore provide quantitative information about molecular composition. [31] [32] [33] Raman spectroscopy has shown acceptable correlation compared with histology (r=0.68 for cholesterol and r=0.71 for calcification) 33 and with IVUS in vitro. 32 Raman spectroscopy technology collects scattered light with optical fibres and routes the collected signal to spectrometer systems for analysis.
Previously, fibre optic probes utilised a region of the Raman spectrum called the 'fingerprint' (FP) region (<~1,800cm -1 shifted light) to conduct remote assays, but due to technical problems with this approach it has recently been replaced by using another region of the Raman spectrum, called high-wavenumber (HW) Raman shifted light (>~2,500 cm -1 shifted light). This allows us to collect Raman spectra via a single optical fibre, simplifying the size and complexity of the catheter and making this method clinically feasible. 34 Thus, the optical catheter system (OCS) (vPredict™) has been introduced as a tool for measuring the chemical composition of coronary vessels in vivo using Raman spectroscopy and the subsequent mapping and quantification of the vessel and plaque components for evaluating plaque progression. In a xenograft model, lipid-laden plaques were identified with the collected Raman spectra by utilising the overall cholesterol content, i.e. the sum of the free cholesterol and cholesterol esters contents, and setting a decision threshold at 12%, as determined in previous studies. As expected, the lipid-laden plaques exhibit an increased free cholesterol and cholesterol ester content, while the non-atherosclerotic samples are mainly protein and triglycerides.
Alternatively, near-infrared (NIR) molecular vibrational transitions can be measured in the NIR region (750-2,500nm), 35 and laser spectroscopy using wavelengths of 360-510nm has been evaluated in vitro. 36 NIR spectroscopy observes how different substances absorb and scatter NIR light to different degrees at various wavelengths. An NIR spectrometer emits light into a sample and measures the proportion of light that is returned over a wide range of optical wavelengths. The return signal is then plotted as a graph of absorbance (y axis) at different wavelengths (x axis), called a spectrum. In aortic and coronary artery autopsy specimens, the ability of the technique to identify lipid-rich TCFA through blood has been confirmed. 37 Initial clinical experience in six patients with stable angina demonstrates that high-quality NIR spectra can be safely obtained. 28 Additional studies are planned to validate the ability of the technique to identify lipid-rich coronary artery plaques and ultimately link chemical characterisation with subsequent occurrence of an ACS. 38, 39 
Treatment
Treatment of asymptomatic, non-obstructive coronary lesions may be a desirable pursuit, but a pre-emptive strike may be a risky, timeconsuming and expensive proposition. Assumptions include:
• accepting that the specific pathology can be defined in living subjects;
• presuming that this particular pathology is responsible for future clinical events; and
• presuming that the 'fingerprint' of this pathology can be reliably detected.
Based on these assumptions, initial risk stratification of asymptomatic patients drawn from the general population will be required, likely using an early screening method able to detect 'non-obstructive highrisk lesions'.
Focal Therapy
Myocardial infarctions are typically the result of focal complex or vulnerable lesions, and it is quite reasonable that many interventionalists Recently, it has been shown that geometrical changes in the shape of the lumen may unfavourably or favourably affect the distribution of local stress, leading to either plaque rupture or reinforcing of the thin fibrous cap. Preliminary data using self-expandable Nitinol-based devices designed with the objective of inducing reinforcement of the cap and necrotic core compression but not cap rupture have been presented. 40, 41 Conceptually, these devices must reinforce the fibrous cap, 're-shape' the necrotic core and mechanically stabilise the lesion at risk of At present, the main purpose of all of these evolving techniques is to improve our understanding of atherosclerotic disease and to define its natural history. Ultimately, the aims are to identify patients at high risk of future cardiovascular events and to evaluate the benefit from either local or systemic therapeutic interventions. ■
